DIRECTED EVOLUTION OF PROTEIN IN MAMMALIAN CELLS

Details for Australian Patent Application No. 2002309989 (hide)

Owner RIGEL PHARMACEUTICALS, INCORPORATED

Inventors PEELLE, Beau

Pub. Number AU-A-2002309989

PCT Number PCT/US02/15968

PCT Pub. Number WO2002/094992

Priority 60/291,871 18.05.01 US

Filing date 20 May 2002

Wipo publication date 3 December 2002

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/291,871 18.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002309989

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002309990-SYSTEM AND METHOD FOR SAMPLING AUDIO RECORDINGS ON A WIRELESS COMMUNICATION DEVICE

2002309988-REACTIVATION OF AROMATICS ALKYLATION CATALYSTS